Characteristics of immediate anti-CD20 adverse drug reactions

被引:0
|
作者
Yotinnoratham, N. [1 ]
Laisuan, W. [1 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
476
引用
收藏
页码:269 / 269
页数:1
相关论文
共 50 条
  • [1] Dental Adverse Effects of Anti-CD20 Therapies
    Bartak, Helene
    Fareh, Tasnim
    Ben Othman, Nouha
    Viard, Delphine
    Cohen, Mikael
    Rocher, Fanny
    Ewig, Elliot
    Drici, Milou-Daniel
    Lebrun-Frenay, Christine
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (03) : 917 - 930
  • [2] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [3] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [4] Immunotherapy with anti-CD20 compounds
    von Schilling, C
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 211 - 222
  • [5] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
  • [6] Anti-CD20 in hematologic oncology
    Milpied, Noel
    [J]. PRESSE MEDICALE, 2009, 38 (05): : 788 - 798
  • [7] ANTI-CD20 MONOCLONAL ANTIBODIES ASSOCIATED COLITIS: ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Alhobayb, Tamara Y.
    Alharfi, Sarah A.
    Cooper, Gregory S.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S206 - S207
  • [8] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [9] Anti-CD20 therapy in rheumatoid arthritis
    Roll, P.
    Tony, H. -P.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 370 - +
  • [10] Anti-CD20 patent battle ends
    Laura DeFrancesco
    [J]. Nature Biotechnology, 2010, 28 (8) : 769 - 769